Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

High-Throughput Assay for RhoGEFs Based on the Transcreener® GDP Assay.

Lowery RG, Kumar M.

Methods Mol Biol. 2018;1821:165-175. doi: 10.1007/978-1-4939-8612-5_12.

PMID:
30062412
2.

A High-Throughput Method for Measuring Drug Residence Time Using the Transcreener ADP Assay.

Kumar M, Lowery RG.

SLAS Discov. 2017 Aug;22(7):915-922. doi: 10.1177/2472555217695080. Epub 2017 Feb 1.

PMID:
28346107
3.

Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.

Zielinski T, Reichman M, Donover PS, Lowery RG.

Assay Drug Dev Technol. 2016 May;14(4):240-51. doi: 10.1089/adt.2016.711. Epub 2016 May 2.

PMID:
27136323
4.

A High-Throughput Assay for Rho Guanine Nucleotide Exchange Factors Based on the Transcreener GDP Assay.

Reichman M, Schabdach A, Kumar M, Zielinski T, Donover PS, Laury-Kleintop LD, Lowery RG.

J Biomol Screen. 2015 Dec;20(10):1294-9. doi: 10.1177/1087057115596326. Epub 2015 Jul 20.

PMID:
26195453
5.

Biochemical Assay Development for Histone Methyltransferases Using a Transcreener-Based Assay for S-Adenosylhomocysteine.

Kumar M, Zielinski T, Lowery RG.

Assay Drug Dev Technol. 2015 May;13(4):200-9. doi: 10.1089/adt.2014.609. Epub 2015 Feb 24.

PMID:
25710335
6.

RGS21, a regulator of taste and mucociliary clearance?

Kimple AJ, Garland AL, Cohen SP, Setola V, Willard FS, Zielinski T, Lowery RG, Tarran R, Siderovski DP.

Laryngoscope. 2014 Mar;124(3):E56-63. doi: 10.1002/lary.24326. Epub 2013 Oct 2.

7.

Evaluating modulators of "Regulator of G-protein Signaling" (RGS) proteins.

Bosch DE, Zielinski T, Lowery RG, Siderovski DP.

Curr Protoc Pharmacol. 2012 Mar;Chapter 2:Unit2.8. doi: 10.1002/0471141755.ph0208s56.

8.

An interview with Robert G. Lowery, PhD. by Vicki Glaser.

Lowery RG.

Assay Drug Dev Technol. 2012 Feb;10(1):1-4. doi: 10.1089/adt.2012.1001.pr. No abstract available.

PMID:
22352940
9.

Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay.

Klink TA, Staeben M, Twesten K, Kopp AL, Kumar M, Dunn RS, Pinchard CA, Kleman-Leyer KM, Klumpp M, Lowery RG.

J Biomol Screen. 2012 Jan;17(1):59-70. doi: 10.1177/1087057111421624. Epub 2011 Sep 28.

10.

ADP detection technologies.

Lowery RG, Vogel K, Till J.

Assay Drug Dev Technol. 2010 Aug;8(4):1-2; author reply 1. doi: 10.1089/adt.2010.0987.letlow. No abstract available.

PMID:
20804418
11.

Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes.

Staeben M, Kleman-Leyer KM, Kopp AL, Westermeyer TA, Lowery RG.

Assay Drug Dev Technol. 2010 Jun;8(3):344-55. doi: 10.1089/adt.2009.0254.

12.

Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity.

Zielinski T, Kimple AJ, Hutsell SQ, Koeff MD, Siderovski DP, Lowery RG.

J Biomol Screen. 2009 Dec;14(10):1195-206. doi: 10.1177/1087057109347473.

13.

Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

Kleman-Leyer KM, Klink TA, Kopp AL, Westermeyer TA, Koeff MD, Larson BR, Worzella TJ, Pinchard CA, van de Kar SA, Zaman GJ, Hornberg JJ, Lowery RG.

Assay Drug Dev Technol. 2009 Feb;7(1):56-67. doi: 10.1089/adt.2008.175.

14.

Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Klink TA, Kleman-Leyer KM, Kopp A, Westermeyer TA, Lowery RG.

J Biomol Screen. 2008 Jul;13(6):476-85. doi: 10.1177/1087057108319864. Epub 2008 Jun 19.

15.

Transcreener: screening enzymes involved in covalent regulation.

Lowery RG, Kleman-Leyer K.

Expert Opin Ther Targets. 2006 Feb;10(1):179-90. Review.

PMID:
16441236
16.

Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.

Ozers MS, Ervin KM, Steffen CL, Fronczak JA, Lebakken CS, Carnahan KA, Lowery RG, Burke TJ.

Mol Endocrinol. 2005 Jan;19(1):25-34. Epub 2004 Sep 16.

PMID:
15375189
17.

Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy.

Coffman BL, Kearney WR, Green MD, Lowery RG, Tephly TR.

Mol Pharmacol. 2001 Jun;59(6):1464-9.

PMID:
11353807
18.

Posttranslational regulatory system for nitrogenase activity in Azospirillum spp.

Fu HA, Hartmann A, Lowery RG, Fitzmaurice WP, Roberts GP, Burris RH.

J Bacteriol. 1989 Sep;171(9):4679-85.

19.

Genes coding for the reversible ADP-ribosylation system of dinitrogenase reductase from Rhodospirillum rubrum.

Fitzmaurice WP, Saari LL, Lowery RG, Ludden PW, Roberts GP.

Mol Gen Genet. 1989 Aug;218(2):340-7.

PMID:
2506427
20.

Supplemental Content

Loading ...
Support Center